Publication — IRIC

A prospective pilot study investigating the musculoskeletal pain in postmenopausal breast cancer patients receiving aromatase inhibitor therapy.

Although arthralgia is a known adverse effect of aromatase inhibitor (ai) treatment in postmenopausal breast cancer patients, few studies have carried out a comprehensive evaluation of the nature, onset, and incidence of musculoskeletal (msk) pain in these patients. We therefore used a pilot study to identify conditions or markers predictive of pain.

Date de publication
1er décembre 2011
Chercheurs
Robidoux A, Rich E, Bureau NJ, Mader S, Laperrière D, Bail M, Tremblay N, Patenaude M, Turgeon J
Référence PubMed
Curr Oncol 2011;18(6):285-94
ID PubMed
22184490
Affiliation
Centre de recherche du Centre hospitalier de l’Université de Montréal, Montreal, QC.